IC
ZBH icon

Intersect Capital’s Zimmer Biomet ZBH Stock Holding History

Intersect Capital’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-41
Closed -$4K – 378
2015
Q1 		$4K Hold
41
– – ﹤0.01% 390
2014
Q4 		$5K Buy
+41
New +$4.32K ﹤0.01% 392

Other funds holding ZBH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Intersect Capital's ZBH Position: Q2 2015 in Review

Intersect Capital sold out of Zimmer Biomet (ZBH) in Q2 2015, closing a stake of 41 shares — an estimated $4K sold.

Intersect Capital first reported a position in ZBH in Q4 2014 and held it in 2 quarters. The position peaked at $5K in Q4 2014. 749 funds tracked by Wall St. Rank hold ZBH as of Q2 2015.

  • Intersect Capital reported no remaining Zimmer Biomet position as of Q2 2015 after selling out during the quarter.
  • Intersect Capital sold 41 Zimmer Biomet shares in Q2 2015, an estimated $4K.
  • Intersect Capital first reported a position in Zimmer Biomet in Q4 2014 and held it in 2 quarters.
  • Intersect Capital's Zimmer Biomet position peaked at $5K in Q4 2014.
  • 749 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2015.

Based on Intersect Capital's 13F filing for Q2 2015, filed 3 Aug 2015.